In-depth understanding of immunological cellular mechanisms provides the basis to explore new ways to modulate the immune system for more effective treatment of cancer
By
Mihai Netea
Biosimilars make certain medicines more affordable, but cost and availability drive the need to find ways to improve access
By
Elisabeth de Vries
National cancer control programmes, pharmaceutical company interest and facilitation of clinical trial participation may be stimulated by epidemiological data
By
Tomohiro Matsuda
Findings call for a change in tumour categorisation, from a cell-of-origin to a tumour microenvironment-associated holistic approach
By
Ton N Schumacher
Ongoing research will help to clarify how CHIP clones may be used to guide therapy for patients with solid tumours
By
Steffen Böttcher
Research is getting closer to the development of patient-specific tailored treatment approaches for brain tumours, thanks to increased understanding of the tumour microenvironment, including the critical importance of the immune system
By
Johanna Joyce
By
Olufunmilayo Olopade
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.